Nathan E. Standifer

2.7k citations
44 papers · 2.2k · 1 hit paper · h-index 20

Impact in

  • Immunology top 5%
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • Immunotherapy and Immune Responses
  • Hepatology top 5%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

    • T-cell and B-cell Immunology 9
    • Immune Cell Function and Interaction 8
    • Immunotherapy and Immune Responses 4
    • Cancer Immunotherapy and Biomarkers 9
    • CAR-T cell therapy research 5

Nathan E. Standifer

44 papers receiving 2.1k citations

Nathan E. Standifer's Hit Papers

Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study 2021 · 370 citations
3700+1+3Years since publication100200300

Peers

Nathan E. Standifer
Comparison fields: 5 of 96
  • Immunology 694
  • Hepatology 237
  • Oncology 492
  • Transplantation 37
  • Genetics 394
Replace Ariella Sasson with:
Ariella Sasson United States
Lothar J. Strobl Germany
Katia Beider Israel
Tom Kay Australia
Yuang‐Taung Juang United States
Min-Jung Lee South Korea
Michele Menicagli Italy
Kellie E. Kolb United States
Joaquı́n Teixidó Spain
Karin List United States
Nathan E. Standifer relative to Ariella Sasson United States Ariella Sasson's profile →
Citations per field
00.5×5×10×16.9×
Ariella Sasson · 1×
Citations per year

Countries citing papers authored by Nathan E. Standifer

Since Specialization
Citations

This map shows the geographic impact of Nathan E. Standifer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan E. Standifer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan E. Standifer more than expected).

Fields of papers citing papers by Nathan E. Standifer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan E. Standifer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan E. Standifer. The network helps show where Nathan E. Standifer may publish in the future.

Co-authors

The 25 scholars most cited alongside Nathan E. Standifer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nathan E. Standifer Line = papers co-authored together Nathan E. Standifer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2006468
2
Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study
Hit paper breakdown →
2021370
3 2018199
4 2010174
5 2011129
6 200691
7 201090
8 200680
9 202167
10 201548
11 202047
12 202441
13 202439
14 202236
15 200927
16 202225
17 201224
18 202323
19 202123
20 202221

About Nathan E. Standifer

Nathan E. Standifer is a scholar working on Immunology, Oncology, Biophysics, Genetics and Hepatology, having authored 44 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), T-cell and B-cell Immunology (9 papers), Diabetes and associated disorders (8 papers), Immune Cell Function and Interaction (8 papers), CAR-T cell therapy research (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Cell Image Analysis Techniques (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Immunology (694 citations), Hepatology (237 citations), Oncology (492 citations), Transplantation (37 citations) and Genetics (394 citations). Nathan E. Standifer has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Gerald T. Nepom, Paul L. Bollyky, Qin Ouyang, Rusung Tan, C. Bruce Verchere, Constadina Panagiotopoulos, Carla J. Greenbaum, William W. Kwok, Xinhui Ge and Eddie A. James. Their work appears in journals such as Annals of Oncology, Clinical Cancer Research, Clinical Immunology, Diabetes and Cytometry Part B Clinical Cytometry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact